• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about psychedelics

Recent news which mentions psychedelics

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
January 09, 2024
Tickers CYBN NEWS
Tags Management Deuterated Psychedelics Psychedelic/Assisted Therapies
From Benzinga
Tryp Therapeutics Explores Psilocybin's Potential In New Trials To Treat IBS And Fibromyalgia
January 08, 2024
Tickers NEWS TRYPF
Tags Markets Psychedelics Penny Stocks
From Benzinga
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
January 08, 2024
Tickers NEWS OPTHF PMBHF
Tags Market News Benzinga Psychedelics Reform
From Benzinga
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
January 07, 2024
Tickers AMA ATAI CMND CMPS
Tags SILO Penny Stocks ATAI
From Benzinga
Veterans Affairs, After Decades, Will Fund Psychedelic Research For Vets With PTSD And Depression
January 06, 2024
Tickers MDMA NEWS
Tags Markets MDMA Government
From Benzinga
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
January 06, 2024
Tickers ATAI CMPS CYBN DMTTF
Tags News Rick Doblin General
From Benzinga
BREAKING: Ibogaine Therapy Show Promising Outcomes For Veterans With Trauma Brain Injury
January 05, 2024
Tickers NEWS
Tags David Esselman Special Operations Veterans Ibogaine Therapy
From Benzinga
Boardroom To Rainforest, Leadership Reimagined With 1heart's Plant Medicine Approach For Global Change
January 04, 2024
Tickers NEWS
Tags Markets Exclusives Interview
From Benzinga
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
January 04, 2024
Tickers ATAI NEWS
Tags ATAI Psychedelics Market News
From Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
January 04, 2024
Tickers ATAI GHRS NEWS
Tags Psychedelics Financing Markets
From Benzinga
AMA's Reimbursement Codes For Psychedelic-Assisted Therapies Take Effect: Here's What To Expect
January 03, 2024
Tickers CMPS NEWS
Tags MAPS PBC Small Cap Benzinga
From Benzinga
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
January 02, 2024
Tickers DEA DMT MDMA NEWS
Tags THC Anne Milgram Market News
From Benzinga
How Magic Mushrooms Affect Each Of The 5 Senses
January 01, 2024
Tags Markets Market News Psilocybin
From Benzinga
Kentucky's Promising Opioid Addiction Treatment Initiative Stalls As New AG Ousts Leading Advocate
December 29, 2023
Tickers NEWS
Tags Legal opioid use disorder Market News
From Benzinga
Fibromyalgia Care Breakthrough: DEA Green Lights Biotech Partnership Exploring Ketamine Implant Therapy
December 28, 2023
Tickers NEWS SILO
Tags Benzinga Ketamine Therapy FDA
From Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap